Catalyst Pharmaceuticals, Inc. (CPRX)
23.20
-0.34
(-1.42%)
USD |
NASDAQ |
Dec 08, 15:48
Catalyst Pharmaceuticals Shareholders Equity (Quarterly): 920.24M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Collegium Pharmaceutical, Inc. | 274.81M |
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| Amicus Therapeutics, Inc. | 230.42M |
| Rigel Pharmaceuticals, Inc. | 117.61M |
| United Therapeutics Corp. | 6.590B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.052B |
| Total Liabilities (Quarterly) | 131.36M |
| Debt to Equity Ratio | 0.0031 |
| Current Ratio | 6.622 |
| Net Debt Paydown Yield | 0.00% |